A structurally distinct arabinose-bridged arabinogalactan from Lycium barbarum as a TLR4-activating adjuvant for nanovaccine-based cancer immunotherapy
Chun‐Jie Bao, Mengqiu Liu, Yanan Liu, Liqiang Zhao, Yuxuan Li, Xin-Lan Zhang, Fang Zhang, Sheng Guo, Erxin Shang, Jia‐Lun Duan, Jin‐Ao Duan
Topics & Concepts
ArabinogalactanAdjuvantImmune systemCancer immunotherapyChemistryCancerPolysaccharideCancer researchProinflammatory cytokineDendritic cellT cellGalactoseAntigenMelanomaImmunotherapyCancer cellBiologyCytokineGlycanCellCell biologyImmunologyBiochemistryAntigen-presenting cellSecretionPolysaccharides and Plant Cell WallsSeaweed-derived Bioactive CompoundsGlycosylation and Glycoproteins Research